Deutsch   English   Français   Italiano  
<20MKp3bUTt4YFg3t_2Crmhb91yc@jntp>

View for Bookmarking (what is this?)
Look up another Usenet article

Path: ...!3.eu.feeder.erje.net!feeder.erje.net!proxad.net!feeder1-2.proxad.net!usenet-fr.net!pasdenom.info!from-devjntp
Message-ID: <20MKp3bUTt4YFg3t_2Crmhb91yc@jntp>
JNTP-Route: nemoweb.net
JNTP-DataType: Article
Subject: Re: L'homologation d'un vaccin =?UTF-8?Q?combin=C3=A9=20grippe-covid=20su?= 
 =?UTF-8?Q?spendue?=
References: <CY3QO.978916$XGr1.929339@fx10.ams4> <JMdRO.1001537$XGr1.26882@fx10.ams4> <vfak88$20itv$1@dont-email.me>
 <16oSO.1015372$Z7Y1.799761@fx14.ams4> <fM6C-kBhjGsjmpmkARFd8tALdHw@jntp> <vg09kq$1lqiu$1@solani.org>
 <YR-0Wt-vUXcbgkm8SJVvntT3-50@jntp> <vg0c38$9hpk$1@solani.org> <KO_RVkjfL1ZJ_khs9XtsplI6-GY@jntp>
 <RgZUO.3246419$grz1.94797@fx03.ams4>
Newsgroups: fr.misc.engueulades
JNTP-HashClient: 8SIFGQ_hysKIueSwRh5IvwmBMfs
JNTP-ThreadID: CY3QO.978916$XGr1.929339@fx10.ams4
JNTP-Uri: https://nemoweb.net/?DataID=20MKp3bUTt4YFg3t_2Crmhb91yc@jntp
User-Agent: Nemo/1.0
JNTP-OriginServer: nemoweb.net
Date: Fri, 01 Nov 24 08:12:47 +0000
Organization: Nemoweb
JNTP-Browser: Mozilla/5.0 (Windows NT 10.0; Win64; x64; rv:132.0) Gecko/20100101 Firefox/132.0
Injection-Info: nemoweb.net; posting-host="48db87d9176ce6969124ceb9d6b05e62333c6c22"; logging-data="2024-11-01T08:12:47Z/9082918"; posting-account="2@nemoweb.net"; mail-complaints-to="julien.arlandis@gmail.com"
JNTP-ProtocolVersion: 0.21.1
JNTP-Server: PhpNemoServer/0.94.5
MIME-Version: 1.0
Content-Type: text/plain; charset=UTF-8; format=flowed
Content-Transfer-Encoding: 8bit
X-JNTP-JsonNewsGateway: 0.96
From: Duzz' <jsuis@jreste.invalid>
Bytes: 2001
Lines: 10

Le 01/11/2024 à 06:01, Paul Aubrin a écrit :
> Le 31/10/2024 à 17:51, Duzz' a écrit :
>>
>>> https://www.vidal.fr/medicaments/substances/ivermectine-4063.html
>> 
>> Merci pour cette explication à l'origine de tes âneries. [2]
> 
> Cet article du Vidal n'est en aucun cas une source d'âneries.

Merci d'avoir confirmé votre ânerie et l'arnaque de sa prescription 
contre le SARS-CoV-2.